HJIM
ASND icon

Henry James International Management’s Ascendis Pharma ASND Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.75M Sell
15,956
-1,895
-11% -$327K 0.91% 36
2025
Q1
$2.78M Hold
17,851
0.95% 34
2024
Q4
$2.46M Sell
17,851
-3,500
-16% -$482K 0.88% 34
2024
Q3
$3.19M Sell
21,351
-3,146
-13% -$470K 1.11% 32
2024
Q2
$3.34M Sell
24,497
-24
-0.1% -$3.27K 1.18% 31
2024
Q1
$3.71M Buy
24,521
+26
+0.1% +$3.93K 1.14% 27
2023
Q4
$3.09M Hold
24,495
1.16% 28
2023
Q3
$2.29M Hold
24,495
0.99% 34
2023
Q2
$2.19M Sell
24,495
-1,522
-6% -$136K 0.95% 31
2023
Q1
$2.79M Sell
26,017
-6
-0% -$643 1.18% 27
2022
Q4
$3.18M Hold
26,023
1.54% 25
2022
Q3
$2.69M Buy
26,023
+2,701
+12% +$279K 1.5% 25
2022
Q2
$2.17M Sell
23,322
-6,400
-22% -$595K 1.09% 31
2022
Q1
$3.49M Sell
29,722
-7,177
-19% -$842K 1.37% 27
2021
Q4
$4.96M Hold
36,899
1.53% 23
2021
Q3
$5.88M Buy
36,899
+1,355
+4% +$216K 1.85% 16
2021
Q2
$4.68M Buy
35,544
+60
+0.2% +$7.89K 1.34% 23
2021
Q1
$4.57M Sell
35,484
-3,299
-9% -$425K 1.38% 22
2020
Q4
$6.47M Hold
38,783
2.25% 12
2020
Q3
$5.99M Buy
38,783
+1
+0% +$154 2.44% 9
2020
Q2
$5.74M Buy
38,782
+18,413
+90% +$2.72M 2.4% 8
2020
Q1
$2.29M Buy
20,369
+11,962
+142% +$1.35M 1.18% 27
2019
Q4
$1.17M Sell
8,407
-4,500
-35% -$626K 0.45% 60
2019
Q3
$1.24M Buy
12,907
+4,500
+54% +$433K 0.53% 48
2019
Q2
$968K Buy
8,407
+4,900
+140% +$564K 0.42% 62
2019
Q1
$413K Buy
+3,507
New +$413K 0.19% 104